Results 181 to 190 of about 914,658 (345)

Experimental and Clinical Pharmacology: Dopamine: clinical applications iii. Cardiovascular

, 1994
Barry P. McGrath, Wang Xhi Qin
openalex   +1 more source

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care.
Amin Mehrabian, Peter Auguste, Amy Grove, Anna Brown, Janette Parr, Mubarak Patel, Furqan Butt, Jeremiah Donoghue, Mehdi Yousefi, Jo Parsons   +9 more
wiley   +1 more source

Cannabidiol in autism: Clinical pharmacology priorities for trial design. [PDF]

Br J Clin Pharmacol
Aragão GF, Brandão CB, Júnior JEL.
europepmc   +1 more source

In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia [PDF]

, 1989
JE Karp, Donehower Rc, JP Enterline, GB Dole, MG Fox, PJ Burke   +5 more
openalex   +1 more source

Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4/MOG‐IgG Dual Seropositive: A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune neuroinflammatory disease, typically characterized by antibodies against aquaporin 4 (AQP4‐IgG) or myelin oligodendrocyte glycoprotein (MOG‐IgG). Simultaneous seropositivity for both antibodies in a single patient is exceedingly rare.
Yeting Luo, Shuhua Xie, Xianghong Liu
wiley   +1 more source

Cardiovascular-Kidney-Metabolic Syndrome in People With HIV: An Emerging Frontier for Clinical Pharmacology. [PDF]

Clin Pharmacol Ther
Devanathan AS, Nolin TD.
europepmc   +1 more source

Preclinical and Clinical Pharmacology of Cyamemazine: Anxiolytic Effects and Prevention of Alcohol and Benzodiazepine Withdrawal Syndrome [PDF]

, 2004
Michel Bourin, Éric Dailly, Martine Hascoët   +2 more
openalex   +1 more source

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source

Draft Guidance on Clinical Pharmacology Studies and on Drug Interaction Studies

, 2001
Toshihiko Ikeda, Minezo OTSUKA, Yasushi Yamazoe   +2 more
openalex   +2 more sources

Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease [PDF]

, 2016
Patricia Muñoz, Juan Segura‐Aguilar
openalex   +1 more source